Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting
Authors:
- Peter T. CampbellPCPeter T. Campbell
- Christine B. AmbrosoneCAChristine B. Ambrosone
- Reiko NishiharaRNReiko Nishihara
- Hugo J. W. L. AertsHAHugo J. W. L. Aerts
- Melissa BondyMBMelissa Bondy
- Nilanjan ChatterjeeNCNilanjan Chatterjee
- Montserrat Garcia-ClosasMGMontserrat Garcia-Closas
- Marios GiannakisMGMarios Giannakis
- Jeffrey A. GoldenJGJeffrey A. Golden
- Yujing J. HengYHYujing J. Heng
- N. Sertac KipNKN. Sertac Kip
- Jill KoshiolJill Koshiol
- 8 May 2019
- journal article
- review article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 30 (8) , 799-811
Abstract
An important premise of epidemiology is that individuals with the same disease share similar underlying etiologies and clinical outcomes. In the past few decades, our knowledge of disease pathogenesis has improved, and disease classification systems have evolved to the point where no complex disease processes are considered homogenous. As a result, pathology and epidemiology have been integrated into the single, unified field of molecular pathological epidemiology (MPE). Advancing integrative molecular and population-level health sciences and addressing the unique research challenges specific to the field of MPE necessitates assembling experts in diverse fields, including epidemiology, pathology, biostatistics, computational biology, bioinformatics, genomics, immunology, and nutritional and environmental sciences. Integrating these seemingly divergent fields can lead to a greater understanding of pathogenic processes. The International MPE Meeting Series fosters discussion that addresses the specific research questions and challenges in this emerging field. The purpose of the meeting series is to: discuss novel methods to integrate pathology and epidemiology; discuss studies that provide pathogenic insights into population impact; and educate next-generation scientists. Herein, we share the proceedings of the Fourth International MPE Meeting, held in Boston, MA, USA, on 30 May–1 June, 2018. Major themes of this meeting included ‘integrated genetic and molecular pathologic epidemiology’, ‘immunology-MPE’, and ‘novel disease phenotyping’. The key priority areas for future research identified by meeting attendees included integration of tumor immunology and cancer disparities into epidemiologic studies, further collaboration between computational and population-level scientists to gain new insight on exposure-disease associations, and future pooling projects of studies with comparable data.Keywords
Funding Information
- National Institutes of Health (NIH R35 CA197735, P30 CA006516, 1R35 CA220523, 1R01 HL111759)
This publication has 86 references indexed in Scilit:
- Passing Messages between Biological Networks to Refine Predicted InteractionsPLOS ONE, 2013
- Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium StudiesJNCI: Journal of the National Cancer Institute, 2010
- Case–Control Study of Overweight, Obesity, and Colorectal Cancer Risk, Overall and by Tumor Microsatellite Instability StatusJNCI: Journal of the National Cancer Institute, 2010
- Early Life Exposure to Famine and Colorectal Cancer Risk: A Role for Epigenetic MechanismsPLOS ONE, 2009
- Physical Activity and Postmenopausal Breast Cancer: Effect Modification by Breast Cancer Subtypes and Effective Periods in LifeCancer Epidemiology, Biomarkers & Prevention, 2008
- Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factorsGut, 2008
- The Stanford Tissue Microarray DatabaseNucleic Acids Research, 2007
- Early Life Factors and Incidence of Proliferative Benign Breast DiseaseCancer Epidemiology, Biomarkers & Prevention, 2005
- Alcohol and Postmenopausal Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Prospective Cohort StudyJNCI: Journal of the National Cancer Institute, 2005
- Ethnicity, Ancestry, and Race in Molecular Epidemiologic ResearchCancer Epidemiology, Biomarkers & Prevention, 2005